Skip to main content

Search

Search the site:

News, Views, and Advocacy From the Oncology Nursing Society

News & Views

Advocacy

Stories

News & Views

Latest Articles
Clinical Practice
ONS News
ONS Leadership

Trending Topics

Treatments
Research
Safety
COVID-19
ONS Congress
Clinical practice

View All Topics

Advocacy

Latest Articles
Updates
Get Involved

Stories View All

View All

Always Search for Ways to Connect With Patients

Oncology nurse-patient relationship

Always Search for Ways to Connect With Patients

September 18, 2020

Word Choice Matters When Caring for Patients With Cancer

Patient empowerment

Word Choice Matters When Caring for Patients With Cancer

September 11, 2020

Learning in the Face of Adversity: Nurse Residency and COVID-19

Learning in the Face of Adversity: Nurse Residency and COVID-19

September 04, 2020

Bedside Nurses Bring Value to Ethical Consults

Ethics in nursing

Bedside Nurses Bring Value to Ethical Consults

August 14, 2020

What’s Working and What Isn’t in Telemedicine

Oncology nurse education

What’s Working and What Isn’t in Telemedicine

Search

News & Views

Advocacy

Stories

Home

Author Content

Cancer healthcare advocacy

Be a Catalyst for Change Like Justice Ginsburg

U.S. Supreme Court Justice Ruth Bader Ginsburg was known for being a fighter—for women’s rights and equality, social justice, and even her own health, battling five bouts of cancer diagnoses. On Friday, September 18, 2020, the 87-year-old passed away from metastatic pancreatic cancer.

September 19, 2020

Cancer research

Medications That Affect Microbiome May Influence Checkpoint Inhibitory Response

Common classes of non-cancer medications that affect a patient’s microbiome are associated with increased or decreased survival with immune checkpoint inhibitor drugs, researchers reported in study findings published in BMC Cancer.

September 16, 2020

Treatment side effects

ONS Guidelines™ Offer Framework for Managing Treatment-Related Hot Flashes

Because of treatment effects on hormones, women with breast cancer and men with prostate cancer have an increased risk of frequent and severe hot flashes after treatment. As many as 80% of patients across both genders experience the symptom, which can have an impact on sleep, mood, energy, and sexual function.

September 10, 2020

Cancer research

MicroRNA May Be Key Factor in High-Grade Ovarian Cancer Development

The miR-181a microRNA may turn off two genes and lead to the development of high-grade serous ovarian cancer, researchers reported in Nature Communications. The finding is significant because not much is known about how ovarian cancer develops and it’s difficult to detect in its earlier stages.

September 09, 2020

Cancer research

Treating Mental Health May Improve Lung Cancer Survival

Patients with lung cancer who also had mental health disorders saw improved cancer-related outcomes when their mental illness was treated, according to findings from a study published in JAMA Oncology.

September 02, 2020

Nurse self-care

PTSD Is More Common Among Nurses Than You May Realize

Almost 96% of nurses report experiencing at least one symptom of post-traumatic stress disorder (PTSD) and nearly 21% meet the criteria for a clinical diagnosis of PTSD, according to findings from a literature review published in the Journal of Clinical Nursing.

August 26, 2020

ACA Led to Higher Rates of Early Breast Cancer Diagnoses

Thanks to expanded Medicaid coverage from the Affordable Care Act (ACA), women diagnosed with breast cancer—and in particular, African American women who are more likely to experience breast cancer disparities—are getting their cancers found at earlier stages, according to researchers. The study findings were reported in JAMA Surgery.

August 19, 2020

Early Use of Immunotherapy Has Better Outcomes for Bladder Cancer

Starting immunotherapy for bladder cancer shortly after initial treatment with chemotherapy is better than taking an extended break from cancer treatment, according to results from a study reported at the American Society of Clinical Oncology annual meeting.

August 12, 2020

Manage Immune-Related Adverse Events in Patients on Durvalumab

Durvalumab immunotherapy became a new standard of care for patients with stage III unresectable non-small cell lung cancer whose disease did not progress following two cycles of platinum-based chemoradiotherapy after its approval in February 2018, and in March 2020, its indication was expanded for use as first-line treatment in patients with extensive-stage small cell lung cancer as well. Key to keeping patients on immunotherapy treatment and giving them the best chance at long-term survival is effective management of immune-related adverse events.

August 11, 2020

Cancer research

A Single Blood Test Could One Day Identify 10 Types of Cancer

When combined with positron-emission and computed tomography, a multicancer blood test identified 10 different tumor types in a sample of women with no history of cancer, researchers reported in Science.

August 05, 2020

Antihistamines May Improve Survival From Malignant Melanoma

Users of two common antihistamines—desloratadine and loratadine—have lower mortality rates from cutaneous malignant melanoma than patients who use other antihistamines, researchers reported in Allergy.

Cancer research

Insulin Resistance May Explain Racial Disparity in Breast Cancer

Black women with breast cancer typically have a worse prognosis than white women, and the results of a new study suggest that insulin resistance may be a factor in the disparity. Findings from the study were reported in Breast Cancer Research.

Opioid-Related Death Rates Are Increasing, But Less So in Cancer Survivors

Although opioid-related deaths are increasing in the general U.S. population, leading to the U.S. Department of Health and Human Services declaring it a public health emergency, new research shows that the increase is much smaller among patients with cancer, even though opioids are used as an option for cancer-related pain. The findings were published in JAMA Oncology.

Oncology nursing roles

Telehealth Boom Opens New Roles for Oncology Nursing

Seemingly overnight, many patients went from viewing telehealth as an intimidating frontier to embracing it with gusto. Fortunately, health care has prepared for years to put the infrastructure and people in place to support telehealth expansion.

Cancer research

Prostate Cancer Clinical Trials Don’t Reflect Racial Diversity—And It’s Getting Worse Over Time

More than 96% of participants in prostate cancer clinical trials are non-Hispanic white men even though non-Hispanic black men represent 22% of prostate cancer diagnoses, researchers reported in Cancer Epidemiology, Biomarkers, and Prevention. Even more critical, enrollment rates of black or African American men have been declining since 1995.

Cancer research

Antibody-Drug Conjugates Join the Best of Two Worlds Into One New Treatment

A new class of drugs, antibody-drug conjugates (ADCs), combines the specificity of targeted therapy with the cytotoxicity of chemotherapy for a powerhouse effect against certain types of cancer variants. Here’s what you need to know about this novel treatment modality.

Polypharmacy Before Cancer Is Predictive of Post-Treatment Hospitalization

Patients who take five or more medications in the six months before beginning IV chemotherapy for a cancer diagnosis are more likely to be hospitalized after their chemotherapy treatment, according to the findings from a new study published in the Journal of Geriatric Oncology.

Cancer research

Exercise Before ADT Treatment Reduces Rate of Side Effects

Beginning a supervised exercise program before the start of androgen deprivation therapy (ADT) for prostate cancer reduced the incidence of treatment-related side effects, researchers reported in a study published in BJU International.

Radiation therapy

Pelvic Radiation May Decrease Bone Mineral Density

Women receiving pelvic radiation therapy for gynecologic cancers are at higher risk for significant decreases in bone mineral density (BMD), with 7.8% of women in the study diagnosed with a pelvic fracture, according to findings from a study published in Cancer.

Manage Late Effects From HPV-Positive Oropharyngeal Cancers

The demographic of patients with oropharyngeal cancers is changing. Clinicians are diagnosing fewer older patients with a long history of heavy smoking and alcohol use; instead, a majority of patients are middle-aged Caucasian men who haven’t smoked but have had multiple sexual partners—and have tested positive for human papillomavirus.

Cancer research

E-Cigarettes Linked to Bladder Cancer Carcinogens

People who use e-cigarettes have six substances that have a strong link to bladder cancer in their urine, researchers reported in European Urology Oncology.

Radiation therapy

Proton Therapy May Reduce Radiation’s Severe Side Effects

Proton beam radiation therapy is safer and equally effective as traditional radiation for adults with advanced cancers, researchers reported in study findings in JAMA Oncology.

Innovative Clinics Help Patients Safely Access Cancer Care During COVID-19

No longer just a convenience, drive-throughs are an essential part of social distancing during the COVID-19 coronavirus pandemic. Retailers and healthcare providers alike have taken it beyond the typical food, prescriptions, and banking, offering everything from merchandise to virus testing—and now, thanks to the innovation of two oncology nurses, cancer care.

Cancer treatments

Investigational Maintenance Therapy Extends Survival in AML

A new drug is extending both remission and survival in adults with acute myeloid leukemia (AML), according to findings reported at the American Society of Hematology annual meeting in December 2019. The study was funded by Celgene, the drug’s manufacturer.

Dietary Supplements May Affect Breast Cancer Chemo Outcomes

Antioxidant supplements are associated with increased disease recurrence and statistically nonsignificant increased risk of mortality in patients with breast cancer who were receiving cyclophosphamide, doxorubicin, and paclitaxel, according to findings from a study reported in the Journal of Clinical Oncology.

Current page 1
Page 2
Page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page

To discuss the information in this article with other oncology nurses, visit the ONS Communities.

To report a content error, inaccuracy, or typo, email pubONSVoice@ons.org.

content['#byline_profile'].image_alt_text

Elisa Becze BA, ELS, Editor

News, Views, and Advocacy From the Oncology Nursing Society

Legal Notices

Contact Us

Conferences

Advertising

Newsroom

Sitemap

Oncology Nursing Foundation

© Copyright 2020 Oncology Nursing Society

Back to Top ▲